Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology

Massive Postpartum Hemorrhage Leads to Sheehan Syndrome; Suture Causes Ovarian Injury

November 19, 2026 Health Desk Health

A 32-year-old mother lost about 5,000 milliliters of blood delivering her first child in July 2024 — roughly ten times the volume of an average postpartum hemorrhage — and the bleeding left her with two separate injuries to her hormone system, Cureus reported in a case study published this month.

Key Clinical Takeaways:

  • Severe postpartum hemorrhage can destroy the pituitary gland (Sheehan syndrome), a condition estimated at 5.1 per 100,000 women in high-income countries and often diagnosed years late.
  • Early warning signs — failed lactation, fatigue, cold intolerance — were present within months but attributed to the trauma of delivery.
  • A displaced B-Lynch compression suture partially amputated the right ovary during emergency surgery, an injury the authors say has not been shown to add hormonal damage.

The report, published in Cureus, documents what the authors call one hemorrhage producing two distinct hypogonadisms. The first is central: Sheehan syndrome, in which ischemic necrosis of the pituitary gland after massive obstetric bleeding shuts down hormone signaling. The second is anatomical: a compression suture that slipped sideways and cut through part of an ovary. Whether the ovarian injury contributed measurable endocrine loss, the authors state, could not be demonstrated.

5,000 Milliliters, Ten Failures

The woman, a 32-year-old first-time mother, reached 41 weeks of gestation with an uneventful pregnancy. After 13 hours with ruptured membranes and severe exhaustion at 7 to 8 centimeters of dilation, she and her partner requested a cesarean delivery. A healthy girl weighing 3,660 grams was born with Apgar scores of 7, 8, and 10, Cureus reported.

The uterus then failed to contract. Uterotonic drugs, tranexamic acid, fibrinogen concentrate, a vacuum-induced intrauterine tamponade, and finally a B-Lynch compression suture all failed to control the bleeding.

In the intensive care unit she reached grade IV hemorrhagic shock: arterial pH of 6.9, lactate of 13 mmol/L, hemoglobin down to 3.3 g/dL, platelets down to 29 × 10⁹/L. Because moving her to an operating room was judged too dangerous, surgeons performed an emergency hysterectomy at the bedside.

That operation revealed the second injury. The B-Lynch suture had slipped laterally and partially amputated the right ovary; a partial right oophorectomy was carried out. Histopathology showed no necrosis in the removed tissue. In total, she received 12 units of packed red blood cells, eight units of fresh frozen plasma, two units of platelets, and a sequence of clotting concentrates. Total estimated blood loss: approximately 5,000 mL.

Lactation Never Started

The first pituitary sign appeared in the hospital. Milk production never began despite regular pumping, and lactation was eventually suppressed with cabergoline. Failure of lactation is one of the most frequent early markers of Sheehan syndrome, the authors note, because prolactin is among the first pituitary outputs to fail after ischemic injury.

Other signs followed through the first postpartum year: exhaustion, poor appetite, cold intolerance, loss of body hair, loss of libido, reduced sweating, vaginal dryness. Each was attributed to the traumatic delivery. She received psychotherapy and sexual therapy; painful intercourse was diagnosed as posttraumatic vaginismus, Cureus reported. The hysterectomy removed a third warning sign — amenorrhea — because without a uterus, absent periods cannot signal anything.

The contrast with the literature is stark. In a retrospective cohort cited in the report, Feinberg and colleagues found Sheehan-like symptoms in roughly one quarter of women after obstetric hemorrhage, yet none of those tested had hormonal evidence of hypopituitarism.

Symptoms alone, the authors caution, do not establish the diagnosis — but because untreated adrenal insufficiency can be fatal, women with severe hemorrhage histories and persistent symptoms should undergo targeted biochemical testing.

Thirteen Months to a Diagnosis

The diagnosis arrived through the thyroid. In August 2025, 13 months after delivery, her general practitioner measured a free thyroxine of 6.6 pmol/L — low — against a thyroid-stimulating hormone of 1.26 mU/L, inappropriately normal. That mismatch pointed upward, to the pituitary, not the gland.

Endocrine assessment at 16 months confirmed the full picture: central hypothyroidism, hypogonadotropic hypogonadism with low gonadotropins and an estradiol of 58 pmol/L, low prolactin, low insulin-like growth factor 1, low ACTH and DHEAS suggesting partial secondary adrenal insufficiency. Pituitary MRI in December 2025 showed a partial empty sella with a very thin adenohypophysis and no mass. Four of the pituitary’s major axes had failed.

Axis affected Laboratory finding Timing
Thyroid Free T4 6.6 pmol/L; TSH 1.26 mU/L 13 months postpartum
Gonadal Estradiol 58 pmol/L with low gonadotropins 16 months postpartum
Adrenal Low ACTH and DHEAS, low-normal morning cortisol 16 months postpartum

Replacing Hormones Around Two Traps

Replacement sequencing followed standard endocrine practice: hydrocortisone first, levothyroxine eight days later, since giving thyroid hormone before cortisol in adrenal insufficiency can precipitate crisis. She received an emergency hydrocortisone kit with stress-dosing instructions.

Estrogen replacement required two detours, Cureus reported. A February 2025 thrombophilia work-up had found a heterozygous prothrombin G20210A mutation, borderline low protein S, and an isolated positive lupus anticoagulant test, so estradiol was given transdermally to avoid first-pass clotting risk.

By May 2026, repeat hemostasis testing on treatment showed normal protein S, a negative lupus anticoagulant, and no markers of coagulation activation. Because a cervical remnant had been found at a hysterectomy documented as total, vaginal micronized progesterone was added in June 2026 as a precaution against any residual endometrial tissue.

Two further decisions remain open. DHEA 25 mg daily, started in June 2026 for persistent loss of libido, showed no benefit after six weeks. And with IGF-1 still low despite normalized thyroid levels, an application for reimbursement of growth hormone (somatropin) was submitted in July 2026.

What Clinicians Should Carry From This Case

The report’s practical weight rests on attribution. Every nonspecific postpartum complaint — fatigue, low mood, cold intolerance — sits at the intersection of anemia, depression, and the aftermath of a near-fatal delivery, and Sheehan syndrome hides behind all three.

Its estimated prevalence of 5.1 per 100,000 women in high-income settings is low, but diagnostic delay in published series stretches to decades, and the untreated adrenal axis is the lethal one. The authors’ position is that severe postpartum hemorrhage plus persistent symptoms warrants targeted pituitary testing, not reassurance.

For women facing a similar recovery, the relevant specialists are endocrinologists experienced in pituitary replacement and maternal-fetal medicine or obstetric teams for any future hemorrhage counseling; a pituitary-specialized center can coordinate dynamic adrenal testing, imaging, and growth hormone assessment that a general work-up may not cover.

The next dated step on record is the somatropin reimbursement decision, submitted in July 2026. Until it resolves, the authors note, IGF-1 remains low at 59 ng/mL on otherwise adequate replacement.

Cureus itself carries an unusual publishing history. The open-access journal began in 2009 under the name PeerEMed and adopted its current name in December 2012. It was founded by two neurosurgeons-turned-editors, John R. Adler of Stanford University and Alexander Muacevic of LMU Munich, who built it around a fast pre-publication peer review supplemented by an optional post-publication rating system called the Scholarly Impact Quotient.

The journal joined the Springer Nature group in December 2022, and case reports such as this one form a substantial share of its output. Its rapid review model has drawn both authors and critics over the years, making it one of the more closely watched outlets in medical publishing.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

More on this story: Benign Diverticulitis and Fat Saponification Mimicking Peritoneal Carcinomatosis and Colonic Malignancy · Gallstone Ileus in a Young Patient With a Large Proximal Jejunal Stone: Case Report and Review

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related reading

  • Orangetheory to Train Coaches With NASM on GLP-1 Weight-Loss Drugs
  • The First Patient, an 81-Year-old Man From Hanoi Identified

Related

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service